Literature DB >> 25984362

Lung cancer screening: identifying the high risk cohort.

Michael W Marcus1, Olaide Y Raji1, John K Field1.   

Abstract

Low dose computed tomography (LDCT) is a viable screening tool for early lung cancer detection and mortality reduction. In practice, the success of any lung cancer screening programme will depend on successful identification of individuals at high risk in order to maximise the benefit-harm ratio. Risk prediction models incorporating multiple risk factors have been recognised as a method of identifying individuals at high risk of developing lung cancer. Identification of individuals at high risk will facilitate early diagnosis, reduce overall costs and also improve the current poor survival from lung cancer. This review summarises the current methods utilised in identifying high risk cohorts for lung cancer as proposed by the Liverpool Lung Project (LLP) risk model, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial risk models and the prediction model for lung cancer death using quintiles. In addition, the cost-effectiveness of CT screening and future perspective for selecting high risk individuals is discussed.

Entities:  

Keywords:  Lung cancer; cohort; high-risk individuals; low dose computed tomography (LDCT); screening

Year:  2015        PMID: 25984362      PMCID: PMC4419032          DOI: 10.3978/j.issn.2072-1439.2015.04.19

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  38 in total

1.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

2.  Lung cancer risk models come of age.

Authors:  John K Field
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

Review 3.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

Review 4.  Lung cancer epidemiology, risk factors, and prevention.

Authors:  Patricia de Groot; Reginald F Munden
Journal:  Radiol Clin North Am       Date:  2012-09       Impact factor: 2.303

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Plasma microRNAs as novel biomarkers for early detection of lung cancer.

Authors:  Dali Zheng; Shadi Haddadin; Yong Wang; Li-Qun Gu; Michael C Perry; Carl E Freter; Michael X Wang
Journal:  Int J Clin Exp Pathol       Date:  2011-08-08

Review 7.  MicroRNA in lung cancer.

Authors:  P-Y Lin; S-L Yu; P-C Yang
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

8.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

9.  Genome-wide association studies in cancer.

Authors:  Douglas F Easton; Rosalind A Eeles
Journal:  Hum Mol Genet       Date:  2008-10-15       Impact factor: 6.150

10.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.

Authors:  Jun Shen; Nevins W Todd; Howard Zhang; Lei Yu; Xing Lingxiao; Yuping Mei; Maria Guarnera; Jipei Liao; Amy Chou; Changwan Larry Lu; Zhengran Jiang; HongBin Fang; Ruth L Katz; Feng Jiang
Journal:  Lab Invest       Date:  2010-11-29       Impact factor: 5.662

View more
  15 in total

1.  Early screening of lung cancers: an effort arduous but worthwhile.

Authors:  Chu Pei; Lawrence Grouse; Guangqiao Zeng
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

Review 2.  Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers.

Authors:  Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2016-12-01       Impact factor: 3.739

Review 3.  [Lung cancer and rheumatoid arthritis. An interdisciplinary challenge].

Authors:  A Rubbert-Roth; T Zander; C Kneitz; C Baerwald; H Wirtz; C Witt
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

4.  Non-intubated thoracoscopic surgery for lung cancer in patients with impaired pulmonary function.

Authors:  Man-Ling Wang; Ming-Hui Hung; Hsao-Hsun Hsu; Kuang-Cheng Chan; Ya-Jung Cheng; Jin-Shing Chen
Journal:  Ann Transl Med       Date:  2019-02

5.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

6.  Severity of pulmonary emphysema and lung cancer: analysis using quantitative lobar emphysema scoring.

Authors:  Kyungsoo Bae; Kyung Nyeo Jeon; Seung Jun Lee; Ho Cheol Kim; Ji Young Ha; Sung Eun Park; Hye Jin Baek; Bo Hwa Choi; Soo Buem Cho; Jin Il Moon
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.

Authors:  Marcela Fu; Noémie Travier; Juan Carlos Martín-Sánchez; Jose M Martínez-Sánchez; Carmen Vidal; Montse Garcia
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

8.  [Surgical Treatment of Small Pulmonary Nodules Under Video-assisted Thoracoscopy 
(A Report of 129 Cases)].

Authors:  Tong Wang; Tiansheng Yan; Feng Wan; Shaohua Ma; Keyi Wang; Jingdi Wang; Jintao Song; Wei He; Jie Bai; Liang Jin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-01-20

9.  Comparison of prevalence and associated factors of depressive disorder between patients with head and neck cancer and those with lung cancer at a tertiary hospital in Taiwan: a cross-sectional study.

Authors:  Yu Lee; Chi-Fa Hung; Chih-Yen Chien; Pao-Yen Lin; Meng-Chih Lin; Chin-Chou Wang; Hung-I Lu; Yung-Che Chen; Mian-Yoon Chong; Liang-Jen Wang
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

Review 10.  Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity.

Authors:  Óscar Rapado-González; Blanca Majem; Laura Muinelo-Romay; Rafa López-López; María Mercedes Suarez-Cunqueiro
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.